IMMUNEERING CORP CLASS A (IMRX) — insider trading
Health Care · NASDAQ
IMMUNEERING CORP CLASS A (IMRX) has 11 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 11 (latest 2026-07-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Gengos Andrew | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 650,000 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Zeskind Benjamin J. | Director, Officer (PRESIDENT AND CEO) | Open-market purchase | 2,400 | $4.56 | $10.9K | Form 4 |
| 2026-06-15 | Hall Brett Matthew | Officer (CHIEF SCIENTIFIC OFFICER) | Open-market purchase | 6,035 | $4.15 | $25.0K | Form 4 |
| 2026-06-11 | Feinberg Peter | Director | Grant / award / vesting (derivative) | 33,350 | $0.00 | $0 | Form 4 |
| 2026-06-11 | KEATING LAURIE | Director | Grant / award / vesting (derivative) | 33,350 | $0.00 | $0 | Form 4 |
| 2026-06-11 | CARPENTER ROBERT J | Director | Grant / award / vesting (derivative) | 33,350 | $0.00 | $0 | Form 4 |
| 2026-06-11 | HAUSMAN DIANA | Director | Grant / award / vesting (derivative) | 33,350 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Schall Thomas J. | Director | Grant / award / vesting (derivative) | 33,350 | $0.00 | $0 | Form 4 |
| 2026-03-13 | Neufeld Leah R | Officer (CHIEF PEOPLE OFFICER) | Grant / award / vesting | 3,628 | $4.29 | $15.6K | Form 4 |
| 2026-02-03 | Brakewood Harold Eugene | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 140,000 | $0.00 | $0 | Form 4 |
| 2026-02-03 | Bookman Michael | Officer (CHIEF LEGAL OFFICER, SECRETARY) | Grant / award / vesting (derivative) | 176,000 | $0.00 | $0 | Form 4 |
Ask the chat about IMRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: IMMUNEERING CORP CLASS A (IMRX).
Last updated 2026-07-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.